Survival among patients who achieved a complete response or minimal disease state prior to salvage therapy with high-dose therapy and autografting (n = 47, solid line) or with conventional salvage therapy (n = 68, dashed line). (A) Overall survival. Log-rank P < .20. (B) Event-free survival. Log-rank P = .06.